Jin Medical International Ltd. Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jin Medical International Ltd. has regained compliance with the Nasdaq Listing Rule 5550(a)(2) Minimum Bid Price Requirement. The company received a notice from the Nasdaq Listing Qualifications Department on April 2, 2026, confirming that its Class A ordinary shares had a closing bid price of $1.00 or greater for ten consecutive business days, from March 16, 2026, to April 1, 2026. This compliance was achieved following a share consolidation approved by the board of directors, effective March 16, 2026, which consolidated shares at a ratio of one-for-twenty. The company had previously been notified of non-compliance and had been granted compliance periods. Jin Medical International Ltd. will continue to focus on its core business operations and strategic initiatives.